Every record from Janoshik · page 36
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020016 | TB-500 | ERP | ERP-2511-L7123 | 2025-Q4 | 99.62 | 4.87 | 101.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019677 | Tirzepatide | Homopeptide | HOMO-2509-U2115 | 2025-Q4 | 98.66 | 2.72 | 92.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019440 | Melanotan II | Homopeptide | HOMO-2505-N9201 | 2025-Q4 | 98.82 | 2.75 | 102.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018594 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 99.51 | 5.10 | 101.0 | Supplier-supplied | 2 | FAIL |
| AX-2025-020631 | Semaglutide | SSA | SSA-2510-C7247 | 2025-Q4 | 99.32 | 3.93 | 100.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019921 | IGF-1 LR3 | SWB | SWB-2505-N5257 | 2025-Q4 | 97.03 | 6.49 | 111.0 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-019617 | GHRP-6 | Homopeptide | HOMO-2505-A1799 | 2025-Q4 | 99.75 | 3.64 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2025-018960 | PT-141 (Bremelanotide) | FGP | FGP-2505-K1249 | 2025-Q4 | 99.20 | 3.55 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021147 | Ipamorelin | WXT | WXT-2510-B5160 | 2025-Q4 | 97.91 | 3.97 | 97.5 | Supplier-supplied | 2 | FAIL |
| AX-2025-021046 | Semaglutide | WXT | WXT-2505-E4164 | 2025-Q4 | 97.82 | 3.11 | 90.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020232 | MOTS-c | GGPeps | GGPE-2508-J1903 | 2025-Q4 | 98.41 | 4.76 | 95.9 | Supplier-supplied | 0 | PASS |
| AX-2025-019618 | GHRP-6 | Homopeptide | HOMO-2505-A1799 | 2025-Q4 | 99.93 | 3.14 | 101.4 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-019163 | Semaglutide | TFC | TFC-2507-U5442 | 2025-Q4 | 98.90 | 4.52 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018961 | PT-141 (Bremelanotide) | FGP | FGP-2505-K1249 | 2025-Q4 | 99.57 | 3.63 | 99.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-018927 | TB-500 | FGP | FGP-2508-S1106 | 2025-Q4 | 99.66 | 4.13 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018598 | GHRP-2 | QYB | QYB-2510-D4955 | 2025-Q4 | 99.04 | 4.33 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019586 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | 2025-Q4 | 99.93 | 5.95 | 94.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019166 | Semaglutide | TFC | TFC-2507-U5442 | 2025-Q4 | 99.26 | 4.14 | 99.1 | Supplier-supplied | 1 | FAIL |
| AX-2025-018528 | IGF-1 DES (1-3) | WWB | WWB-2505-N4242 | 2025-Q4 | 99.62 | 4.53 | 90.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020871 | CJC-1295 (no DAC) | CPC | CPC-2509-L1903 | 2025-Q4 | 98.23 | 6.11 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020512 | TB-500 | KP | KP-2510-V5596 | 2025-Q4 | 99.11 | 4.53 | 103.3 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020468 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.83 | 4.66 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019122 | IGF-1 DES (1-3) | JEEP | JEEP-2510-M4682 | 2025-Q4 | 99.75 | 2.72 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018479 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | 2025-Q4 | 99.07 | 3.45 | — | Supplier-supplied | 0 | PASS |
| AX-2025-021104 | Semaglutide | WXT | WXT-2507-N4828 | 2025-Q4 | 97.20 | 4.64 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-020983 | Melanotan II | CPC | CPC-2506-W3648 | 2025-Q4 | 99.30 | 5.84 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021284 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2510-P7196 | 2025-Q4 | 98.12 | 4.99 | 103.7 | Buyer-sourced | 2 | FAIL |
| AX-2025-019964 | BPC-157 | SWB | SWB-2511-N6092 | 2025-Q4 | 98.73 | 6.55 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019406 | Tirzepatide | Homopeptide | HOMO-2510-E8656 | 2025-Q4 | 98.59 | 4.81 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018544 | Semax | WWB | WWB-2506-S4098 | 2025-Q4 | 98.92 | 8.08 | 105.3 | Laboratory-retained | 0 | PASS |
| AX-2025-021176 | Retatrutide | WXT | WXT-2505-X5572 | 2025-Q4 | 97.35 | 2.98 | 99.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019965 | BPC-157 | SWB | SWB-2511-N6092 | 2025-Q4 | 98.83 | 7.09 | 99.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019663 | SS-31 (Elamipretide) | Homopeptide | HOMO-2507-B2039 | 2025-Q4 | 99.08 | 6.29 | 103.9 | Supplier-supplied | 0 | PASS |
| AX-2025-019029 | Retatrutide | JEEP | JEEP-2510-W2963 | 2025-Q4 | 98.64 | 6.02 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018915 | Semaglutide | FGP | FGP-2506-J9812 | 2025-Q4 | 99.47 | 4.35 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020231 | MOTS-c | GGPeps | GGPE-2508-J1903 | 2025-Q4 | 98.36 | 4.39 | 104.6 | Buyer-sourced | 0 | PASS |
| AX-2025-020230 | Cagrilintide | GGPeps | GGPE-2507-Y1706 | 2025-Q4 | 98.22 | 1.64 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019255 | Selank | TFC | TFC-2511-C6410 | 2025-Q4 | 99.43 | 8.32 | 95.5 | Supplier-supplied | 0 | PASS |
| AX-2025-021160 | TB-500 | WXT | WXT-2502-A5571 | 2025-Q3 | 99.17 | 2.90 | 107.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019162 | Selank | TFC | TFC-2505-A5030 | 2025-Q4 | 98.40 | 8.00 | — | Supplier-supplied | 1 | FAIL |